or Try an Advanced Search...

    Blastoma Stocks List

    Symbol Grade Name % Change
    UTHR A United Therapeutics Corporation 0.00
    DCPH A Deciphera Pharmaceuticals, Inc. 0.12
    CRVO B CervoMed Inc. 0.00
    CLLS C Cellectis S.A. 0.00
    AEZS C AEterna Zentaris Inc. 0.00
    PSTV C Plus Therapeutics, Inc. 0.00
    NVCR C NovoCure Limited 1.28
    PRLD D Prelude Therapeutics Incorporated 0.00
    CLDX D Celldex Therapeutics, Inc. 3.80
    CLRB D Cellectar Biosciences, Inc. 2.20
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Cancer Glioblastoma Medicine Biopharmaceutical Solid Tumors Clinical Development Clinical Medicine Oncology Biotechnology Brain Tumor Cancer Treatment Glioblastoma Multiforme Ovarian Cancer Antineoplastic Drugs Brain Cancer Chemotherapy Drugs Immune System Lymphoma Multiple Myeloma

    Related ETFs - A few ETFs which own one or more of the above listed Blastoma stocks.

    Symbol Grade Name Weight
    PBE B PowerShares Dynamic Biotech & Genome 6.28
    BBP C BioShares Biotechnology Products Fund 5.21
    PJP A PowerShares Dynamic Pharmaceuticals 4.4
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 3.88
    FBT C First Trust Amex Biotech Index Fund 3.71
    View all Blastoma ETFs...
    Compare ETFs
    Compare PBE to BBP Compare PBE to FBT Compare PJP to FBT

        Blastoma Stocks Recent News

        Date Stock Title
        May 15 AEZS MT Newswires Canada Overnight Stocks To Watch: Aeterna Zentaris; Orla Mining; Andlauer Healthcare; CES Energy Solutions; Imperial Metals; Sulliden
        May 14 AEZS Aeterna Zentaris Reports First Quarter 2024 Financial Results
        May 14 CLRB Cellectar Biosciences, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 14 CLRB Cellectar Biosciences, Inc. (CLRB) Q1 2024 Earnings Call Transcript
        May 14 UTHR Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
        May 14 CLRB Cellectar Biosciences GAAP EPS of -$0.74 misses by $0.18
        May 14 CLRB Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
        May 13 CLRB Cellectar Biosciences Q1 2024 Earnings Preview
        May 10 UTHR Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
        May 10 UTHR Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
        May 10 CLDX Celldex Therapeutics: Rising High, With Room For Further Growth
        May 10 DCPH Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
        May 10 DCPH Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
        May 9 UTHR CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
        May 9 CLDX Wall Street Analysts Believe Celldex (CLDX) Could Rally 67.77%: Here's is How to Trade
        May 9 PRLD Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
        May 8 PSTV Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
        May 8 UTHR Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Cancer Glioblastoma Medicine Biopharmaceutical Solid Tumors Clinical Development Clinical Medicine Oncology Biotechnology Brain Tumor Cancer Treatment Glioblastoma Multiforme Ovarian Cancer Antineoplastic Drugs Brain Cancer Chemotherapy Drugs Immune System Lymphoma Multiple Myeloma
        Blastoma

        A blastoma is a type of cancer, more common in children, that is caused by malignancies in precursor cells, often called blasts. Examples are nephroblastoma, medulloblastoma, and retinoblastoma. The suffix -blastoma is used to imply a tumor of primitive, incompletely differentiated (or precursor) cells, e.g., chondroblastoma is composed of cells resembling the precursor of chondrocytes.

        More about Blastoma
        Browse All Tags